Klinikum Schwabing

Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI): Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments (2020) von Scheidt W, Welz A, Pauschinger M, Fischlein T, Schächinger V, Treede H, Zahn R, et al. Journal article High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution BRAF inhibitor treatment in hairy cell leukemia: a long-term follow up study (2019) Liebers N, Roider T, Bohn JP, Pircher A, Ferstl B, Ebnoether M, Perker M, et al. Conference contribution BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials (2019) Liebers N, Roider T, Bohn JP, Haberbosch I, Pircher A, Ferstl B, Ebnöther M, et al. Journal article Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis (2019) Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, Peest D, et al. Journal article Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases (2018) Wermann WK, Viardot A, Kayser S, Alakel N, Elmaagacli A, Faul C, Fiedler W, et al. Conference contribution DNA Damage-Response Pathway in Lymphoma Determines Interactions with Macrophages By Altered PD-Li Expression and Fxosome Formation (2018) Vorholt D, Izquierdo-Alvarez E, Sackey B, Schmitz J, Nickel N, Blakemore S, Knittel G, et al. Conference contribution Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) (2018) Larocca A, Dold SM, Zweegman S, Terpos E, Waesch R, D'Agostino M, Scheubeck S, et al. Journal article, Review article Risk of second cancer following radiotherapy for prostate cancer: A population-based analysis (2017) Hegemann NS, Schlesinger-Raab A, Ganswindt U, Horl C, Combs SE, Holzel D, Gschwend JE, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article